TY - JOUR
T1 - Incidence and Outcomes of Desmoplastic Small Round Cell Tumor
T2 - Results from the Surveillance, Epidemiology, and End Results Database
AU - Lettieri, Christina K.
AU - Garcia-Filion, Pamela
AU - Hingorani, Pooja
N1 - Publisher Copyright:
© 2014 Christina K. Lettieri et al.
PY - 2014
Y1 - 2014
N2 - Desmoplastic small round cell tumor (DSRCT) is a rare but highly fatal malignancy. Due to the rarity of this neoplasm, no large population based studies exist. Procedure. This is a retrospective cohort analysis. Incidence rates were calculated based on sex and ethnicity and compared statistically. Gender-, ethnicity-, and treatment-based survival were calculated using the Kaplan-Meier method. Results. A total of 192 cases of DSRCT were identified. Peak incidence age was between 20 and 24 years. Age-adjusted incidence rate for blacks was 0.5 cases/million and for whites was 0.2 cases/million (P = 0.037). There was no statistically significant difference in survival based on gender or ethnicity. When adjusted for age, there was no statistically significant difference in survival amongst patients who received radiation therapy compared to those who did not (HRadj = 0.73; 95% CI 0.49, 1.11). There was a statistically significant survival advantage for patients who received radiation after surgery compared to those who did not (HR 0.49; 95% CI 0.30, 0.79). Conclusion. DSRCT is more common in males and in people of African-American descent. Although overall survival remains poor, radiation therapy following surgery seems to improve outcome in these patients.
AB - Desmoplastic small round cell tumor (DSRCT) is a rare but highly fatal malignancy. Due to the rarity of this neoplasm, no large population based studies exist. Procedure. This is a retrospective cohort analysis. Incidence rates were calculated based on sex and ethnicity and compared statistically. Gender-, ethnicity-, and treatment-based survival were calculated using the Kaplan-Meier method. Results. A total of 192 cases of DSRCT were identified. Peak incidence age was between 20 and 24 years. Age-adjusted incidence rate for blacks was 0.5 cases/million and for whites was 0.2 cases/million (P = 0.037). There was no statistically significant difference in survival based on gender or ethnicity. When adjusted for age, there was no statistically significant difference in survival amongst patients who received radiation therapy compared to those who did not (HRadj = 0.73; 95% CI 0.49, 1.11). There was a statistically significant survival advantage for patients who received radiation after surgery compared to those who did not (HR 0.49; 95% CI 0.30, 0.79). Conclusion. DSRCT is more common in males and in people of African-American descent. Although overall survival remains poor, radiation therapy following surgery seems to improve outcome in these patients.
UR - http://www.scopus.com/inward/record.url?scp=84934975426&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84934975426&partnerID=8YFLogxK
U2 - 10.1155/2014/680126
DO - 10.1155/2014/680126
M3 - Article
C2 - 25431592
AN - SCOPUS:84934975426
SN - 1687-8558
VL - 2014
JO - Journal of Cancer Epidemiology
JF - Journal of Cancer Epidemiology
M1 - 680126
ER -